View Clinical Trial (Medical Research Study)


Efficacy of Topical Cyclosporin for Ocular Rosacea - NCT00348335-11790(Clinical Trial 308176)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  StonyBrook
State:  
NY
Zip Code: 11790
Conditions: Rosacea
Purpose: The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
Study summary: The study is designed to compare the efficacy of topical cyclosporin (Restasis) with that of Refresh Endura for the treatment of the signs and symptoms of ocular rosacea in patients presently controlled on topical corticosteroids
Criteria: Inclusion Criteria: - Pt at least 18 yrs but younger than 65 Diagnosis of acne rosacea active ocular rosacea based on lid findings of meibomian gland dysfunction with lid telangectasia and hyperemia of at least 2+ Schirmers test of greater than 5mm in at least 1 eye If patient currently using lid hygiene must maintain regimen during study Stop oral antibiotics at least 4 weeks prior Exclusion Criteria: - Use of topical cyclosporin within last 90 days Visual acuity of 20/100 or better in both eyes Pregnant or lactating females Active ocular infection Scarring of central cornea Eyelid defects,abnormal lid positioning or lagophthalmos Flax seed or Fish oil supplements within last 30 days
Study is available at: 2500 Rte 347 Bldg 24
StonyBrook, NY 11790
United States

Primary Contact:
John R Wittpenn
Email: jwittpenn@ocli.net
Phone: 631-941-1400
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.